These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 26035469)

  • 1. Combining randomized and non-randomized evidence in clinical research: a review of methods and applications.
    Verde PE; Ohmann C
    Res Synth Methods; 2015 Mar; 6(1):45-62. PubMed ID: 26035469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporating data from various trial designs into a mixed treatment comparison model.
    Schmitz S; Adams R; Walsh C
    Stat Med; 2013 Jul; 32(17):2935-49. PubMed ID: 23440610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accounting for uncertainty due to 'last observation carried forward' outcome imputation in a meta-analysis model.
    Dimitrakopoulou V; Efthimiou O; Leucht S; Salanti G
    Stat Med; 2015 Feb; 34(5):742-52. PubMed ID: 25492741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Building a Bayesian bridge from evidence to guidelines.
    Goodman SN
    Arch Intern Med; 2009 Aug; 169(15):1436-7. PubMed ID: 19667309
    [No Abstract]   [Full Text] [Related]  

  • 6. Practical and updated guidelines on performing meta-analyses of non-randomized studies in interventional cardiology.
    Navarese EP; Koziński M; Pafundi T; Andreotti F; Buffon A; Servi SD; Kubica J
    Cardiol J; 2011; 18(1):3-7. PubMed ID: 21305479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bayesian classification of clinical practice guidelines.
    Diamond GA; Kaul S
    Arch Intern Med; 2009 Aug; 169(15):1431-5. PubMed ID: 19667308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Danger of misuse of meta-analyses for observational studies based on published data.
    Sauerbrei W; Blettner M
    Stud Health Technol Inform; 2000; 77():33. PubMed ID: 11187567
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis of observational studies with unmeasured confounders.
    McCandless LC
    Int J Biostat; 2012 Jan; 8(2):. PubMed ID: 22499731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of repeated measures study designs.
    Peters JL; Mengersen KL
    J Eval Clin Pract; 2008 Oct; 14(5):941-50. PubMed ID: 19018929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hierarchical metaregression approach and learning from clinical evidence.
    Verde PE
    Biom J; 2019 May; 61(3):535-557. PubMed ID: 30600534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and adjusting for small-study effects in meta-analysis.
    Rücker G; Carpenter JR; Schwarzer G
    Biom J; 2011 Mar; 53(2):351-68. PubMed ID: 21374698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for planning and designing meta-analysis in oral medicine.
    Pinto A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):194-202. PubMed ID: 23663987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to Bayesian modelling in dental research.
    Gilthorpe MS; Maddick IH; Petrie A
    Community Dent Health; 2000 Dec; 17(4):218-21. PubMed ID: 11191195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Data mining and statistically guided clinical review of adverse event data in clinical trials.
    Southworth H; O'Connell M
    J Biopharm Stat; 2009 Sep; 19(5):803-17. PubMed ID: 20183445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-regression with partial information on summary trial or patient characteristics.
    Hemming K; Hutton JL; Maguire MG; Marson AG
    Stat Med; 2010 May; 29(12):1312-24. PubMed ID: 20087842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Bayesian analyses to doubly randomized delayed start, matched control designs to demonstrate disease modification.
    Turkoz I; Sobel M; Alphs L
    Pharm Stat; 2019 Jan; 18(1):22-38. PubMed ID: 30221459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation study comparing exposure matching with regression adjustment in an observational safety setting with group sequential monitoring.
    Stratton KG; Cook AJ; Jackson LA; Nelson JC
    Stat Med; 2015 Mar; 34(7):1117-33. PubMed ID: 25510526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories.
    Govan L; Ades AE; Weir CJ; Welton NJ; Langhorne P
    Stat Med; 2010 May; 29(12):1340-56. PubMed ID: 20191599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials.
    Clayton GL; Smith IL; Higgins JPT; Mihaylova B; Thorpe B; Cicero R; Lokuge K; Forman JR; Tierney JF; White IR; Sharples LD; Jones HE
    Trials; 2017 May; 18(1):219. PubMed ID: 28506284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.